CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence

CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence

David M Richards, Christian Merz, Christian Gieffers, Andriy Krendyukov Apogenix AG, Heidelberg, GermanyCorrespondence: Andriy Krendyukov Tel +49 6221 5860877Email andriy.krendyukov@apogenix.comAbstract: The ability of FasL/CD95L to induce apoptosis in various Fas/CD95-expressing cells has been desc...

Full description

Bibliographic Details
Main Authors: Richards DM, Merz C, Gieffers C, Krendyukov A
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Cancer Management and Research
Subjects:
fasl/cd95l
anti-tumor immune response
immune checkpoint
tumor microenvironment
novel therapeutic target
Online Access:https://www.dovepress.com/cd95l-and-anti-tumor-immune-response-current-understanding-and-new-evi-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/cd95l-and-anti-tumor-immune-response-current-understanding-and-new-evi-peer-reviewed-article-CMAR

Similar Items